Berjame, Angelita R.
HRN: 17-64-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2023
CEFTRIAXONE 1G (VIAL)
09/07/2023
09/13/2023
IVT
2g
OD
Ulcerated Breast Mass L; Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes